TABLE 1

99mTc-(CO)3 His-annexin A5 Uptake in Tumors

Time after NaCl or irinotecan treatment (h) (n = 3)
122448
Bevacizumab at…NaClIrinotecanNaClIrinotecanNaClIrinotecan
2 d81.55 ± 4.63102.76 ± 11.09103.70 ± 31.3192.43 ± 7.77104.26 ± 30.25162.20 ± 31.20*
4 d76.76 ± 19.6077.15 ± 19.5171.31 ± 9.52232.78 ± 24.82**79.74 ± 17.61117.05 ± 28.70
6 d73.93 ± 16.5376.36 ± 27.7897.29 ± 18.90126.94 ± 20.71102.50 ± 29.63109.52 ± 29.81

  • ↵* P < 0.05.

  • Data are expressed as %ID/tumor weight (g)/body weight (kg) and normalized to controls (n = 9) and are mean ± SD.